Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
Open Access
- 28 May 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 9 (1), 81
- https://doi.org/10.1186/1479-5876-9-81
Abstract
Background: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is characterised by severe prolonged fatigue, and decreases in cognition and other physiological functions, resulting in severe loss of quality of life, difficult clinical management and high costs to the health care system. To date there is no proven pathomechanism to satisfactorily explain this disorder. Studies have identified abnormalities in immune function but these data are inconsistent. We investigated the profile of markers of immune function (including novel markers) in CFS/ME patients.Methods: We included 95 CFS/ME patients and 50 healthy controls. All participants were assessed on natural killer (NK) and CD8+T cell cytotoxic activities, Th1 and Th2 cytokine profile of CD4+T cells, expression of vasoactive intestinal peptide receptor 2 (VPACR2), levels of NK phenotypes (CD56brightand CD56dim) and regulatory T cells expressing FoxP3 transcription factor.Results: Compared to healthy individuals, CFS/ME patients displayed significant increases in IL-10, IFN-γ, TNF-α, CD4+CD25+T cells, FoxP3 and VPACR2 expression. Cytotoxic activity of NK and CD8+T cells and NK phenotypes, in particular the CD56brightNK cells were significantly decreased in CFS/ME patients. Additionally granzyme A and granzyme K expression were reduced while expression levels of perforin were significantly increased in the CFS/ME population relative to the control population. These data suggest significant dysregulation of the immune system in CFS/ME patients.Conclusions: Our study found immunological abnormalities which may serve as biomarkers in CFS/ME patients with potential for an application as a diagnostic tool.This publication has 50 references indexed in Scilit:
- Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labelingJournal of the Neurological Sciences, 2011
- A formal analysis of cytokine networks in Chronic Fatigue SyndromeBrain, Behavior, and Immunity, 2010
- Cytokines across the Night in Chronic Fatigue Syndrome with and without FibromyalgiaClinical and Vaccine Immunology, 2010
- Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-1) in Patients with Gastric CancerJournal of Biomedicine and Biotechnology, 2010
- Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic MelanomaClinical Cancer Research, 2009
- Immunological aspects of chronic fatigue syndromeAutoimmunity Reviews, 2009
- Chronic fatigue syndrome with autoantibodies — The result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implantAutoimmunity Reviews, 2008
- Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell DeathAnnual Review of Immunology, 2008
- Infection-induced viscerosensory signals from the gut enhance anxiety: Implications for psychoneuroimmunologyBrain, Behavior, and Immunity, 2007
- Elevations in IL-10, TNF-α, and IFN-γfrom the Earliest Point of HIV Type 1 InfectionAIDS Research and Human Retroviruses, 2006